MedPath

Clinical study of wet age-related macular degeneration with Traditional Chinese medicine and Western medicine

Not Applicable
Not yet recruiting
Conditions
wet age-related macular degeneration
Registration Number
ITMCTR2200006375
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Any one eye meets the western diagnostic criteria of wet AMD;
2) Age =50;
3) Intravitreal injection of anti-VEGF drugs is required
4) The refractive stroma is basically clear, fundus examination and fundus OCTA are feasible;
5) Patients had good compliance with the observation and efficacy evaluation of the study and signed informed consent.

Exclusion Criteria

1) The refractive medium is not clear enough to conduct fundus observer.
2) Combined with glaucoma, uveitis, severe cataract, vitreous hematocele, fundus vein obstruction, optic neuritis, retinal detachment and other ophthalmic diseases affecting vision or effect observation.
3) Patients who have received fundus surgery and laser treatment
4) Patients who had received intravitreal drug injection in last 3 months
5) complicated with other organs (such as heart, brain, liver) and other serious diseases, or mental patients.
6) Women who are pregnant, trying to become pregnant or breastfeeding.
7) Severe allergy to fluorescein sodium and indocyanqing green needles.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.